Alps Advisors Inc Catalent, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $3,226 - $4,219	-37 Reduced 1.02%	3,593 $385,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $341,909 - $451,898	3,630 New	3,630 $403,000
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $357,750 - $466,480	-3,277 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$101.51 - $125.27 $17,256 - $21,295	170 Added 5.47%	3,277 $345,000
Q4 2020 Feb 03, 2021	SELL	$85.88 - $105.36 $8,158 - $10,009	-95 Reduced 2.97%	3,107 $323,000
Q3 2020 Nov 04, 2020	BUY	$72.74 - $92.5 $232,913 - $296,185	3,202 New	3,202 $274,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.